BioSpace News Archive

Rakuten Medical, Inc., a global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox™, will present at the 39th Annual J.P. Morgan Healthcare Conference being held virtually January 11-14, 2021.

Cerecor Inc., a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced that it has entered into an underwriting agreement with Jefferies LLC under which the underwriters agreed to purchase, on a firm commitment basis, 12,323,077 shares of common stock of the Company, at a public offering price of $2.60 per share.

Vapotherm to Present at the 23 rd Annual ICR/Westwicke Conference

Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced its Chief Executive Officer, John Fowler, will present a corporate overview at the H.C. Wainwright Virtual BioConnect Conference, being held on January 11-14, 2021. The presentation will be available on Monday, Januar

BENEV Company Inc. is proud to announce that that the 12-week Prospective, Double-blind, Randomized, Split-face Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2 Laser for Acne Scars by ExoCoBio Inc., an equity invested partner of BENEV, was published on Oct 19th, 2020, in Acta Dermato-Venereologica.

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2021 on Thursday, January 28, 2021, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details:

According to the report titled ‘Global Orthopedic Braces & Supports Market Size study, by Product (Lower Extremity Braces and Supports, Spinal Braces and Supports, Upper Extremity Braces and Supports), By End-user (Hospitals, Orthopedic Centers and Others) and Regional Forecasts 2020-2027’, available with Market Study Report LLC, global orthopedic braces & supports market was worth USD 2.90 billion in 2019 and is expected to record a 5.8% CAGR during 2020-2027.

Increasing number of injuries to caregivers while manually handling patients coupled with strict regulatory outlook associated with safe patient handling are key factors driving the growth of global patient lateral transfer market. As per Family Caregiver Alliance, over 34 million American caregivers were prone to operational hazards in the year 2019 while providing homecare services.

Increasing pervasiveness of chronic diseases such as cancer, heart ailments, and diabetes, leading to subsequent demand for organ visualization is primarily driving the growth of global ultrasound market. According to European Heart Network (EHN) report, cardiovascular diseases caused 3.9 million deaths in Europe in 2017, accounting for 45% of total mortality.

AdaptHealth Corp., a leading provider of home medical equipment, supplies and related services in the United States, announced that Luke McGee, Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 at 10:00 am EST.